Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Topsun Pharmaceutical appears to be a China-based small-molecule pharmaceutical manufacturer operating in Huainan, Anhui. Public company-registry and profile sources indicate it manufactures finished dosage forms and active pharmaceutical ingredients, with listed products including mesalazine, niclosamide, paracetamol, metronidazole, procaine hydrochloride, sodium phenytoin, aspirin, and proglumide. The business is not an innovation-stage biotech developer; rather, it looks like a commercial manufacturing company focused on generic pharmaceuticals, APIs, and related chemical production. The company is active and operates under Hengcheng Pharmaceutical Group, following prior historical names including Anhui Dongsheng Pharmaceutical and Guoyi Pharmaceutical. Available evidence also suggests it has had drug-manufacturing and related chemical-production capabilities, with commercial operations centered in Anhui, China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Topsun Pharmaceutical.